Evidence map›Paper›PMID 29758386›Full record

ArticleNeuropharmacology2018

The neurokinin-1 receptor mediates escalated alcohol intake induced by multiple drinking models.

Michelle K Sequeira, Britta S Nelson, Hannah D Fulenwider, Courtney E King, Sadie E Nennig, Jennifer B Bohannon, Kejun Cheng, Kenner C Rice, Markus Heilig, Jesse R Schank

Open access · greenAbstract read
In one paragraph

Article in Neuropharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Yohimbine as a pharmacological probe for alcohol research: a systematic review of rodent and human studies.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Michelle K SequeiraDepartment of Physiology and Pharmacology, University of Georgia, Athens, GA, USA.
Britta S NelsonDepartment of Physiology and Pharmacology, University of Georgia, Athens, GA, USA.
Hannah D FulenwiderDepartment of Physiology and Pharmacology, University of Georgia, Athens, GA, USA.
Courtney E KingLab of Clinical and Translational Studies, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, USA.
Sadie E NennigDepartment of Physiology and Pharmacology, University of Georgia, Athens, GA, USA.
Jennifer B BohannonDepartment of Physiology and Pharmacology, University of Georgia, Athens, GA, USA.
Kejun ChengSection on Drug Design and Synthesis, National Institute on Alcohol Abuse and Alcoholism and National Institute on Drug Abuse, Bethesda, MD, USA.
Kenner C RiceSection on Drug Design and Synthesis, National Institute on Alcohol Abuse and Alcoholism and National Institute on Drug Abuse, Bethesda, MD, USA.
Markus HeiligLab of Clinical and Translational Studies, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, USA.
Jesse R SchankDepartment of Physiology and Pharmacology, University of Georgia, Athens, GA, USA. Electronic address: jschank@uga.edu.
University of Georgia · USNational Institute on Alcohol Abuse and Alcoholism · USNational Institute on Drug Abuse · US

Funding

Medicinal Chemistry of Drugs Acting on Central and Peripheral Opioid ReceptorsZIADA000527 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI RICE, KENNER · 2009 to 2025
$23.2M
Medicinal Chemistry of Drugs Acting on Central and Peripheral Opioid ReceptorsZ01DA000527 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI RICE, KENNER · 2008 to 2008
$2.1M
The Role of the Neurokinin-1 Receptor and NF kappa B in alcohol-induced behaviorR00AA021805 · NIAAA · UNIVERSITY OF GEORGIA · PI SCHANK, JESSE R · 2014 to 2016
$724k
Intramural NIH HHS Z01 DA000527NIAAA NIH HHS R00 AA021805
6 · The paper itself

Abstract

We have previously demonstrated that the neurokinin-1 receptor (NK1R) is upregulated in the central nucleus of the amygdala of alcohol preferring (P) rats and that this receptor mediates escalated alcohol consumption in this strain. However, it is unclear if non-genetic models of escalated consumption are also mediated by NK1R signaling, and if so, what brain regions govern this effect. In the experiments presented here, we use two methods of inducing escalated alcohol intake in outbred Wistar rats: yohimbine pretreatment and intermittent alcohol access (Monday, Wednesday, and Friday availability; 20% alcohol). We found that escalated alcohol consumption induced by both yohimbine injection and intermittent access is attenuated by systemic administration of the NK1R antagonist L822429. Also, when compared to continuous alcohol access or access to water alone, NK1R expression was increased in the nucleus accumbens (NAC) and dorsal striatum, but not the amygdala. Escalated consumption induced by intermittent access was attenuated when the NK1R antagonist L822429 was infused directly into the dorsal striatum, but not when infused into the NAC. Taken together, these results suggest that NK1R upregulation contributes to escalated alcohol consumption that is induced by genetic selection, yohimbine injection, and intermittent access. However there is a dissociation between the regions involved in these behaviors with amygdalar upregulation contributing to genetic predisposition to escalated consumption and striatal upregulation driving escalation that is induced by environmental exposures.

Indexed as

Adrenergic alpha-2 Receptor AntagonistsAlcohol DeterrentsAlcohol DrinkingAlcohol-Related DisordersAmygdalaAnimalsAnimals, Outbred StrainsCorpus StriatumDisease Models, AnimalGene Expression RegulationMaleNeurokinin-1 Receptor AntagonistsNucleus AccumbensPiperidinesRats, WistarReceptors, Neurokinin-1Adrenergic alpha-2 Receptor AntagonistsAlcohol DeterrentsN-((2-cyclopropoxy-5-(5-trifluomethyl)tetrazol-1-yl)benzyl)-2-phenylpiperidin-3-amineNeurokinin-1 Receptor AntagonistsPiperidinesReceptors, Neurokinin-1YohimbineAlcoholEscalationIntermittent accessNeurokininStriatum

Identifiers

PMID29758386
PMCPMC6701855
OpenAlexW2801659703

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.